Enfusion Inc (ENFN) stock saw a modest uptick, ending the day at $10.96 which represents a slight increase of $0.04 or 0.37% from the prior close of $10.92. The stock opened at $10.95 and touched a ...

NEW YORK, NY / ACCESSWIRE / January 15, 2025 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Enfusion, Inc. (NYSE: ENFN) to Clearwater Analytics for $5.85 per share in cash and $5.40 per share in Clearwater ...

Morgan Stanley has recently resumed Enfusion Inc (ENFN) stock to Overweight rating, as announced on May 10, 2024, according to Finviz. Earlier, on February 28, 2024, Goldman had reduced the stock from ...

NEW YORK CITY, NY / ACCESSWIRE / January 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between ...

Fintel reports that on January 13, 2025, William Blair downgraded their outlook for Enfusion (NYSE:ENFN) from Outperform to ...

Clearwater Analytics (NYSE:CWAN) has agreed to acquire Enfusion (NYSE:ENFN) for $11.25 a share, delivered in an approximately ...

NYSE:ENFN) The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Enfusion, Inc. For Securities Fraud ...

NEW YORK & LONDON & HONG KONG, November 20, 2024--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced ...

ENFN) Click to Take Action Enfusion, Inc. has entered into a definitive agreement with Clearwater Analytics. The purchase price is $11.25 per share, delivered in an approximately equal mix of cash ...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are ...

It is free and there is no cost or obligation to you. Enfusion, Inc. (NYSE: ENFN), relating to the proposed merger with Clearwater Analytics. Under the terms of the agreement, Enfusion ...